Company / CapEx per Share
Twist Bioscience Corp CapEx per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.47
FY2025
5-year range
$0.09 / $1.89
FY2021-FY2025
Trend
+435.2%
vs FY2024
Sector context
#26 of 190
Health Care
What the data says
CapEx per Share changed +435% YoY in FY2025, a notable deviation from the 8-year average annual change of +6063204%.
Based on SEC 10-K filings.
0.47 in FY2025 with a 5-year CAGR of +13.2%. Top quartile in the Health Care sector.
Declined from $0.49 to $0.47 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -37.2%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 190This company $0.47 Sector average $2.49
▼
-81.2% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 435.2% year-over-year.
- Ranks #26 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | +435.2% |
| FY2024 | $0.09 | -82.1% |
| FY2023 | $0.49 | -74.2% |
| FY2022 | $1.89 | +237.0% |
| FY2021 | $0.56 | +122.7% |
| FY2020 | $0.25 | -53.1% |
| FY2019 | $0.54 | -100.0% |
| FY2018 | $1320.44 | +48505149.6% |
| FY2017 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026